Finding Your Rhythm: Optimizing IL-23 Inhibitor Use in IBD
This activity is supported by an educational grant from Johnson & Johnson.
Don’t miss these 4 satellite symposia at the ACG 2026 Annual Scientific Meeting! Featuring expert faculty, interactive learning formats, and practical clinical insights, these programs offer physicians and advanced practice providers specializing in gastroenterology an opportunity to stay ahead of the rapidly evolving treatment landscape in inflammatory bowel disease (IBD) and eosinophilic esophagitis (EoE).
This activity is supported by an educational grant from Johnson & Johnson.
This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc. and Sanofi.
